SCHEMBL661017

SCHEMBL661017

Nc1ncc(-c2cn[nH]c2)c2cc(Cl)oc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K7 O43318 7/20 0.43
TAB1 Q15750 7/20 0.43
LRRK2 Q5S007 1/20 0.43
MET P08581 2/20 0.37
FEN1 P39748 2/20 0.35
BTK Q06187 1/20 0.35
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
TYK2 P29597 1/20 0.35
JAK3 P52333 1/20 0.35
AURKB Q96GD4 2/20 0.34
AURKA O14965 1/20 0.34
INCENP Q9NQS7 1/20 0.34
TPX2 Q9ULW0 1/20 0.34
MAP4K3 Q8IVH8 2/20 0.33
IKBKE Q14164 1/20 0.32
TBK1 Q9UHD2 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12444023 0.71 MAP3K7 (0.74) MAP3K7TAB1AURKBKDR
SCHEMBL12443842 0.71 MAP3K7 (0.54) MAP3K7TAB1LRRK2BTKAURKB
SCHEMBL658949 0.69 IDO1 (0.32)
SCHEMBL10270915 0.67 MAP3K7 (0.41) MAP3K7TAB1LRRK2AURKBKDR
SCHEMBL31403817 0.67 LRRK2 (0.46) LRRK2FEN1BTKAURKBAURKA
SCHEMBL22777207 0.65 LRRK2 (0.57) LRRK2FEN1BTKJAK2JAK1
SCHEMBL21405437 0.65 LRRK2 (0.47) LRRK2METFEN1BTKJAK2
SCHEMBL30725521 0.64 DHFR (0.47) LRRK2FEN1BTKAURKBAURKA
SCHEMBL10267357 0.64 LRRK2 (0.46) MAP3K7TAB1LRRK2METFEN1
SCHEMBL24533140 0.62 LRRK2 (0.41) LRRK2FEN1BTKJAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 MAP3K7 5/4885TAB1 4/4885LRRK2 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.